The influence of hormonal replacement therapy on immune system in patients with hypergonadotropic ovarian insufficiency

Cover Page


Cite item

Full Text

Abstract

Objective: To study the influence of steroid hormones on interferon (IFN) status indices and cytotoxic activity of natural killer (NK)-cells index in patients with hypergonadotropic ovarian insufficiency.

Full Text

Objective: To study the influence of steroid hormones on interferon (IFN) status indices and cytotoxic activity of natural killer (NK)-cells index in patients with hypergonadotropic ovarian insufficiency.

Methods: 20 patients with secondary hypergonadotropic amenorea (23-37 yrs.) were examined; the control consisted of 28 healthy women of reproductive age. All women had normal female caryotype 46/XX. IFN status and cytotoxic activity of NK-cells indices were investigated in the blood serum before and during cyclic hormonal replacement therapy (HRT).

Results: The initial cytotoxic activity of NK-cells and IFN status indices were higher then in control (p<0.05). Under the influence of estradiol there was a decrease of cytotoxic activity of NK-cells index by 18.9%, production of IFN-a/b — by 19.5% and IFN-g - by 37.5% (p<0.01). Against the background of maximum progesterone influence the cytotoxic activity of NK-cells increased by 8% (p<0.05), IFN-g production - by 19% (p<0.01) and IFN-a/b production - by 9% (p>0.05). Common serum IFN indices before and during HRT were higher than in control (p<0.05).

Conclusions: The results demonstrate the influence of sexual steroid hormones on leukocytes ability to produce IFN-a/b/g and cytotoxic activity of NK-cells and allow to assume that estrogens in the progesterone deficiency favour the decrease of these indices. Gestagens, in their turn, stimulate the leukocytes ability to produce IFN-a/b/g and cytotoxic activity of NK-cells.

×

About the authors

E. I. Abashova

D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences

Email: info@eco-vector.com
Russian Federation, Saint-Petersburg

V. V. Poteen

D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences

Email: info@eco-vector.com
Russian Federation, Saint-Petersburg

V. V. Rulev

D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences

Email: info@eco-vector.com
Russian Federation, Saint-Petersburg

S. A. Selkov

D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences

Email: info@eco-vector.com
Russian Federation, Saint-Petersburg

V. V. Grigorjeva

D.O. Ott Institute of Obstetrics and Gynecology, Russian Academy of Medical Sciences

Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Saint-Petersburg

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 1999 Eсо-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 66759 от 08.08.2016 г. 
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия Эл № 77 - 6389
от 15.07.2002 г.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies